Preferred Label : Abciximab;
MeSH definition : A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein
IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA
COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory
unstable angina, and for prevention of ischemic complications in patients undergoing
percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting.;
MeSH synonym : c7E3 Fab; Chimeric 7E3 Fab; Fab, Chimeric 7E3;
MeSH Related Number : 143653-53-6 (Abciximab);
Wikipedia link : https://en.wikipedia.org/wiki/Abciximab;
UNII : X85G7936GV;
Origin ID : D000077284;
UMLS CUI : C0288672;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
- abciximab [International Nonproprietary Name]
MeSH indexing information
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
- abciximab [International Nonproprietary Name]
A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein
IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA
COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory
unstable angina, and for prevention of ischemic complications in patients undergoing
percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting.
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64735468
2008
France
French
platelet aggregation inhibitors
immunoglobulin fab fragments
antibodies, monoclonal
injections, intravenous
infusions, intravenous
antibodies, monoclonal
drug therapy, combination
adult
drug interactions
pharmaceutical solutions
platelet aggregation inhibitors
treatment outcome
drug approval
drug storage
drug compounding
abciximab
summary of product characteristics
package leaflet
Abciximab
Abciximab
---